Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(24):1804-1805; doi:10.1093/jnci/dji458
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vastag, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vastag, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Consumer Groups Look To Improve Adverse Event Reporting Systems

Brian Vastag

The first 10% of the full text of this article appears below.

Few multiple myeloma patients, let alone anyone else, had heard of osteonecrosis in 2001. The rare affliction, in which bone marrow dies and bones collapse, is found most often in the hip. But starting in 2002, patients with multiple myeloma began turning up with bone deformities in their jaws.

Robert Kyle, M.D., a noted myeloma specialist at the Mayo Clinic, Rochester, Minn., remarked that in his 40 years of practice, he had never seen osteonecrosis of the jaw. And yet, in 2003 and 2004, oral surgeons published reports of dozens of myeloma and other cancer patients with the potentially disfiguring disorder.

Michael Katz, of the International Myeloma Foundation, a patient advocacy organization, said online discussion groups soon made a link: the jaw problems appeared only . . . [Full Text of this Article]

Many Reports


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?